Unnecessary Controversy Regarding Dietary Sodium: A Lot About a Little

Canadian Journal of Cardiology

Volumn 27, Issue 4, 2011, Pages 404-406

  Campbell, Norman R C ^a   Cappuccio, Francesco P ^b   Tobe, Sheldon W ^c  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF WARWICK   (United Kingdom)

^c SUNNYBROOK RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BODY MASS; CARDIOVASCULAR DISEASE; EDITORIAL; HUMAN; HYPERTENSION; NONHUMAN; PATIENT MONITORING; RISK ASSESSMENT; SALT INTAKE; SODIUM INTAKE; STROKE; VASCULAR DISEASE;

CARDIOVASCULAR DISEASES; DIET, SODIUM-RESTRICTED; HUMANS; RISK FACTORS; SODIUM, DIETARY;

EID: 80052404935     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cjca.2011.05.003     Document Type: Editorial

References (24)

1. Stolarz-Skrzypek K., Kuznetsova T., Thijs L., et al. Fatal and nonfatal outcomes, incidence of hypertension, and blood pressure changes in relation to urinary sodium excretion. JAMA 2011, 305:1777-1785.
2. Strazzullo P., D'Elia L., Kandala N.B., Cappuccio F.P. Salt intake, stroke, and cardiovascular disease: meta-analysis of prospective studies. BMJ 2009, 339:b4567.
3. Khan N.A., Hemmelgarn B.R., Padwal R., et al. The 2007 Canadian Hypertension Education Program recommendations for the management of hypertension: part 2: therapy. Can J Cardiol 2007, 23:539-550.
4. Salt and Health 2003, 1-134. Scientific Advisory Committee on Nutrition, Stationery Office, Norwich, UK.
5. Dickinson B.D., Havas S. Reducing the population burden of cardiovascular disease by reducing sodium intake: a report of the Council on Science and Public Health. Arch Intern Med 2007, 167:1460-1468.
6. Reducing salt intake in populations: report of a WHO forum and technical meeting 5-7 October 2006, Paris, France 2007, 1-65. World Health Organization, World Health Organization, Geneva, Switzerland.
7. Dietary reference intakes for water, potassium, sodium, chloride and sulfate 2004, 1-640. Panel on Dietary Reference Intakes for Electrolytes and Water, Standing Committee on the Scientific Evaluation of Dietary Reference Intakes, National Academies Press, Washington, DC.
8. Appel L.J., Frohlich E.D., Hall J.E., et al. The importance of population-wide sodium reduction as a means to prevent cardiovascular disease and stroke: a call to action from the American Heart Association. Circulation 2011, 123:1138-1143.
9. Bibbins-Domingo K., Chertow G.M., Coxson P.G., et al. Projected effect of dietary salt reductions on future cardiovascular disease. N Engl J Med 2010, 362:590-599.
10. Joffres M., Campbell N.R.C., Manns B., Tu K. Estimate of the benefits of a population-based reduction in dietary sodium additives on hypertension and its related health care costs in Canada. Can J Cardiol 2007, 23:437-443.
11. Asaria P., Chisholm D., Mathers C., Ezzati M., Beaglehole R. Chronic disease prevention: health effects and financial costs of strategies to reduce salt intake and control tobacco use. Lancet 2007, 370:2044-2053.
12. Cohen H.W., Hailpern S.M., Fang J., Alderman M.H. Sodium intake and mortality in the NHANES II follow-up study. Am J Med 2006, 119:e7-e14.
13. Liu K., Cooper R., McKeever J., et al. Assessment of the association between habitual salt intake and high blood pressure: methodological problems. Am J Epidemiol 1979, 110:219-226.
14. MacGregor G.A., Markandu N.D., Sagnella G.A., Singer D.R., Cappuccio F.P. Double-blind study of three sodium intakes and long-term effects of sodium restriction in essential hypertension. Lancet 1989, 2:1244-1247.
15. Sacks F.M., Svetkey L.P., Vollmer W.M., et al. Effects on blood pressure of reduced dietary sodium and the dietary approaches to stop hypertension (DASH) diet. N Engl J Med 2001, 344:3-10.
16. Brown I.J., Tzoulaki I., Candeias V., Elliott P. Salt intakes around the world: implications for public health. Int J Epidemiol 2009, 38:791-813.
17. Curtis R., Larson J.C., Delzell E., et al. Placebo adherence, clinical outcomes, and mortality in the Women's Health Initiative Randomized Hormone Therapy Trials. Med Care 2011, 49:427-435.
18. Avins A.L., Pressman A., Ackerson L., Rudd P., Neuhaus J., Vittinghoff E. Placebo adherence and its association with morbidity and mortality in the studies of left ventricular dysfunction. J Gen Intern Med 2010, 25:1275-1281.
19. A population-based policy and systems change approach to prevent and control hypertension. National Academy of Sciences, 2010 Committee on Public Health Priorities to Reduce and Control Hypertension in the U.S.Population, Board on Population Health and Public Health Practice, Institute of Medicine, Accessed May 19, 2011. http://books.nap.edu/openbook.php?record_id=12819.
20. Logan A.G. Dietary sodium intake and its relation to human health: a summary of the evidence. J Am Coll Nutr 2006, 25:4F-169F.
21. Midgley J.P., Matthew A.G., Greenwood C.M., Logan A.G. Effect of reduced dietary sodium on blood pressure: a meta-analysis of randomized controlled trials. JAMA 1996, 275:1590-1597.
22. Van Vliet B.N., Campbell N.R.C. Efforts to reduce sodium intake in Canada: why, what, and when?. Can J Cardiol 2011, 27:437-445. Canadian Hypertension Eduction Program.
23. Danaei G., Ding E.L., Mozaffarian D., et al. The preventable causes of death in the United States: comparative risk assessment of dietary, lifestyle, and metabolic risk factors. PLoS Med 2009, 6:e1000058.
24. He F.J., MacGregor G.A. A comprehensive review on salt and health and current experience of worldwide salt reduction programmes. J Hum Hypertens 2009, 23:363-384.